165 related articles for article (PubMed ID: 16797516)
21. Lipoprotein (a) and comprehensive lipid tetrad index as a marker for coronary artery disease in NIDDM patients in South India.
Rajappa M; Sridhar MG; Balachander J; Sethuraman KR
Clin Chim Acta; 2006 Oct; 372(1-2):70-5. PubMed ID: 16701602
[TBL] [Abstract][Full Text] [Related]
22. Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus.
Camuzcuoglu H; Toy H; Cakir H; Celik H; Erel O
J Womens Health (Larchmt); 2009 Sep; 18(9):1435-9. PubMed ID: 19698032
[TBL] [Abstract][Full Text] [Related]
23. Paraoxonase activity following exercise-based cardiac rehabilitation program.
Goldhammer E; Ben-Sira D; Zaid G; Biniamini Y; Maor I; Lanir A; Sagiv M
J Cardiopulm Rehabil Prev; 2007; 27(3):151-4. PubMed ID: 17558196
[TBL] [Abstract][Full Text] [Related]
24. Fluoroscopic coronary calcification and exercise stress test in asymptomatic elderly Asian-Indians.
Singh NK; Narang R; Dey AB
Indian Heart J; 2008; 60(4):302-8. PubMed ID: 19242006
[TBL] [Abstract][Full Text] [Related]
25. Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease.
Balcerzyk A; Zak I; Krauze J
Arch Med Res; 2007 Jul; 38(5):545-50. PubMed ID: 17560461
[TBL] [Abstract][Full Text] [Related]
26. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
[TBL] [Abstract][Full Text] [Related]
27. Association between human paraoxonase 1 activity and intima-media thickness in subjects under 55 years of age with carotid artery disease.
Harangi M; Seres I; Magyar MT; Csipo I; Sipka S; Valikovics A; Csiba L; Bereczki D; Paragh G
Cerebrovasc Dis; 2008; 25(1-2):122-8. PubMed ID: 18073465
[TBL] [Abstract][Full Text] [Related]
28. Homocysteine and lipid levels in young patients with coronary artery disease.
Puri A; Gupta OK; Dwivedi RN; Bharadwaj RP; Narain VS; Singh S
J Assoc Physicians India; 2003 Jul; 51():681-5. PubMed ID: 14621037
[TBL] [Abstract][Full Text] [Related]
29. Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women.
Zornitzki T; Ayzenberg O; Gandelman G; Vered S; Yaskil E; Faraggi D; Caspi A; Goland S; Shvez O; Schattner A; Knobler H
QJM; 2007 Sep; 100(9):575-81. PubMed ID: 17693419
[TBL] [Abstract][Full Text] [Related]
30. Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease.
Serdar Z; Aslan K; Dirican M; Sarandöl E; Yeşilbursa D; Serdar A
Clin Biochem; 2006 Aug; 39(8):794-803. PubMed ID: 16600205
[TBL] [Abstract][Full Text] [Related]
31. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
Carević V; Rumboldt M; Rumboldt Z;
Acta Med Croatica; 2007 Jun; 61(3):299-306. PubMed ID: 17629106
[TBL] [Abstract][Full Text] [Related]
32. Premature coronary artery disease: role of free radical nitric oxide.
Ravi Kanth VV; Prakash GJ; Naik S; Kabra N; Sujatha M
Indian Heart J; 2008; 60(1):45-9. PubMed ID: 19212021
[TBL] [Abstract][Full Text] [Related]
33. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
[TBL] [Abstract][Full Text] [Related]
34. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
Ding J; Chen Q; Zhuang X; Feng Z; Xu L; Chen F
Med Sci Monit; 2014 Nov; 20():2421-9. PubMed ID: 25420483
[TBL] [Abstract][Full Text] [Related]
35. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
[TBL] [Abstract][Full Text] [Related]
36. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
37. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey.
Onat A; Hergenç G; Uyarel H; Can G; Ozhan H
Anadolu Kardiyol Derg; 2006 Dec; 6(4):314-21. PubMed ID: 17162275
[TBL] [Abstract][Full Text] [Related]
38. Association of cys 311 ser polymorphism of paraoxonase-2 gene with the risk of coronary artery disease.
Jalilian A; Javadi E; Akrami M; Fakhrzadeh H; Heshmat R; Rahmani M; Bandarian F
Arch Iran Med; 2008 Sep; 11(5):544-9. PubMed ID: 18759523
[TBL] [Abstract][Full Text] [Related]
39. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
40. Determinants of coronary artery disease in nondiabetic hemodialysis patients: a matched case-control study.
Zumrutdal A; Baltali M; Micozkadioglu H; Torun D; Sezer S; Ozdemir FN; Haberal M
Ren Fail; 2007; 29(1):67-71. PubMed ID: 17365912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
